It has been reported that glioblastoma tumors develop resistance to temozolomide therapy due to overexpression of GLI1, and that GLI1 imparts stem cell like properties to cancer cells rendering them ineffective to chemotherapy [1]. Here, GLI1 is linked to cancer.